Publisher
Public Library of Science (PLoS)
Reference9 articles.
1. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association;AJ Camm;Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol,2012
2. Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. Rhythm control and cardioversion;N Sulke;Heart Br Card Soc,2007
3. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial;C Stellbrink;Circulation,2004
4. 16 DC Cardioversion Cancellations Due to Inadequate Anticoagulation-frequency and Cost;O Pampolini-Roberts;Heart,2014
5. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study;Am Heart J,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献